On the other hand, coordinated up-regulation of KLK5, 6, 7, 8, 10, 11 and 14 in ovarian cancer [74] and down-regulation of KLK5, 6, 8, and 10 in breast cancer [75] has been observed. This evidence concerns the gene KLK5 and breast carcinoma.